Clinical trial

Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe)

NCT00162929

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-01-01

PhasePHASE1

Study timeline

Study start (unknown)2005-01-01Date precision: month

Registry last updated2012-06-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Breast Cancerunresolved

Interventions

AdHer-2/neu transduced dendritic cellsBIOLOGICAL

Sponsors & collaborators

Ontario Clinical Oncology Group (OCOG)lead sponsor

Ontario Cancer Research Networkcollaborator

Canadian Breast Cancer Research Alliancecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00162929 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.